Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16215968 | 0.83 | — | — | |
| SCHEMBL6851256 | 0.76 | — | — | |
| SCHEMBL7216876 | 0.76 | KDM4E (0.37) | KDM4ELMNAGABRR1 | |
| SCHEMBL22051412 | 0.74 | — | — | |
| SCHEMBL18103601 | 0.74 | LTA4H (0.35) | — | |
| SCHEMBL16454939 | 0.72 | ANPEP (0.33) | — | |
| SCHEMBL17347959 | 0.71 | SLC7A5 (0.41) | — | |
| SCHEMBL10140648 | 0.70 | — | — | |
| SCHEMBL20978336 | 0.70 | — | — | |
| SCHEMBL14306757 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1996609-B1 | METHOD OF PREPARING GLYCOPEPTIDES | SCRIPPS RESEARCH INST (US) | 2016-08-03 | — | — | EP | disclosed |
| US-20150343080-A1 | GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS | NOVO NORDISK AS (DK) | 2015-12-03 | — | — | US | disclosed |
| US-8816050-B2 | Method of preparing glycopeptides | THE SCRIPPS RESEARCH INSTITUTE | 2014-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150343080-A1 | GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS | PTMS, ANPEP, NGLY1 | KDM4E 3684/4885LMNA 1603/4885GABRR1 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.